Physician profile
Randall S Prust
NPI 1033116611
$1,106.04
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $635 · 2020: $271 · 2021: $160 · 2022: $13.10 · 2023: $13.30 · 2024: $14.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $27.91.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $27.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $501.65 | 2019-2024 | Eterna |
| Novartis Pharmaceuticals Corporation | $105.43 | 2019-2021 | |
| Allergan, INC. | $99.39 | 2020-2021 | |
| Scilex Pharmaceuticals INC. | $77.64 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $53.44 | 2020-2021 | |
| Lilly USA, LLC | $51.45 | 2019-2020 | |
| Amgen INC. | $44.35 | 2019-2020 | |
| Nevro Corp. | $30.92 | 2019 | |
| Stryker Corporation | $24.65 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $19.42 | 2021 | |
| Medtronic USA, INC. | $18.02 | 2020 | |
| Medtronic, INC. | $14.93 | 2021 | |
| Daiichi Sankyo INC. | $13.55 | 2019 | |
| Zyla Life Sciences, INC. | $13.42 | 2019 | |
| Radius Health, INC. | $13.10 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vanda Pharmaceuticals INC. | $12.75 | 2019 | |
| Stimwave Technologies Incorporated | $11.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randall Prust listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.